DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Raymond James Maintains Outperform on ANI Pharmaceuticals, Lowers Price Target to $65

Raymond James maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Outperform and lowers the price target from $75 to $65.

Benzinga · 02/28/2020 12:47

Raymond James maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Outperform and lowers the price target from $75 to $65.